The potential of dietary treatment in patients with glycogen storage disease type IV

There is paucity of literature on dietary treatment in Glycogen Storage Disease (GSD) type IV and formal guidelines are not available. Traditionally, liver transplantation was considered the only treatment option for GSD IV. In light of the success of dietary treatment for the other hepatic forms of GSD, we have initiated this observational study to assess the outcomes of medical diets which limit the accumulation of glycogen. Clinical, dietary, laboratory and imaging data for 15 GSD IV patients from three centres are presented. Medical diets may have the potential to delay or prevent liver transplantation, improve growth and normalize serum aminotransferases. Individual care plans aim to avoid both hyperglycaemia, hypoglycaemia and/or hyperketosis, to minimize glycogen accumulation and catabolism, respectively. Multidisciplinary monitoring includes balancing between traditional markers of metabolic control (i.e. growth, liver size, serum aminotransferases, glucose homeostasis, lactate and ketones), liver function (i.e. synthesis, bile flow and detoxification of protein) and symptoms and signs of portal hypertension. This article is protected by copyright. All rights reserved.